Citron Research Challenges Jim Cramer on Palantir Valuation Concerns
Citron Research Takes on Jim Cramer Renowned short-seller Andrew Left, representing Citron Research, has publicly critiqued Jim Cramer, a prominent figure on CNBC, regarding his optimistic view on Palantir Technologies Inc. Background of the Disagreement The clash became evident when Cramer enthusiastically tweeted about Palantir's prospects, mentioning a bold $200 price...
Continue Reading